Artificial Pancreas Systems Market Size, Share, and Growth Forecast 2026 – 2033

The global artificial pancreas systems market size is expected to be valued at US$ 312.3 million in 2026 and projected to reach US$ 657.5 million by 2033, growing at a CAGR of 11.2% between 2026 and 2033.

The market expansion is driven by the rising global diabetes burden, with the IDF Diabetes Atlas estimating that 589 million adults live with diabetes in 2024, projected to reach 853 million by 2050. Regulatory approvals for advanced hybrid closed-loop systems from Medtronic, Tandem, Insulet, and Beta Bionics have accelerated adoption, demonstrating significant improvements in time-in-range and HbA1c reduction across clinical trials and real-world use.